305 related articles for article (PubMed ID: 10931944)
21. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
[TBL] [Abstract][Full Text] [Related]
22. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
23. High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD.
Gibbs EM; Marshall JL; Ma E; Nguyen TM; Hong G; Lam JS; Spencer MJ; Crosbie-Watson RH
Hum Mol Genet; 2016 Dec; 25(24):5395-5406. PubMed ID: 27798107
[TBL] [Abstract][Full Text] [Related]
24. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC
Sci Transl Med; 2012 Dec; 4(164):164ra160. PubMed ID: 23241744
[TBL] [Abstract][Full Text] [Related]
25. Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.
Culligan K; Glover L; Dowling P; Ohlendieck K
BMC Cell Biol; 2001; 2():2. PubMed ID: 11178104
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.
Li H; Mittal A; Makonchuk DY; Bhatnagar S; Kumar A
Hum Mol Genet; 2009 Jul; 18(14):2584-98. PubMed ID: 19401296
[TBL] [Abstract][Full Text] [Related]
27. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice.
Whitehead NP; Pham C; Gervasio OL; Allen DG
J Physiol; 2008 Apr; 586(7):2003-14. PubMed ID: 18258657
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice.
Jayasinha V; Nguyen HH; Xia B; Kammesheidt A; Hoyte K; Martin PT
Neuromuscul Disord; 2003 Jun; 13(5):365-75. PubMed ID: 12798792
[TBL] [Abstract][Full Text] [Related]
30. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
[TBL] [Abstract][Full Text] [Related]
31. PTRH2 gene mutation causes progressive congenital skeletal muscle pathology.
Doe J; Kaindl AM; Jijiwa M; de la Vega M; Hu H; Griffiths GS; Fontelonga TM; Barraza P; Cruz V; Van Ry P; Ramos JW; Burkin DJ; Matter ML
Hum Mol Genet; 2017 Apr; 26(8):1458-1464. PubMed ID: 28175314
[TBL] [Abstract][Full Text] [Related]
32. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
33. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
34. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ
Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
36. Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models.
Yu L; Zhang X; Yang Y; Li D; Tang K; Zhao Z; He W; Wang C; Sahoo N; Converso-Baran K; Davis CS; Brooks SV; Bigot A; Calvo R; Martinez NJ; Southall N; Hu X; Marugan J; Ferrer M; Xu H
Sci Adv; 2020 Feb; 6(6):eaaz2736. PubMed ID: 32128386
[TBL] [Abstract][Full Text] [Related]
37. Microtubules underlie dysfunction in duchenne muscular dystrophy.
Khairallah RJ; Shi G; Sbrana F; Prosser BL; Borroto C; Mazaitis MJ; Hoffman EP; Mahurkar A; Sachs F; Sun Y; Chen YW; Raiteri R; Lederer WJ; Dorsey SG; Ward CW
Sci Signal; 2012 Aug; 5(236):ra56. PubMed ID: 22871609
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
Alexander MS; Casar JC; Motohashi N; Vieira NM; Eisenberg I; Marshall JL; Gasperini MJ; Lek A; Myers JA; Estrella EA; Kang PB; Shapiro F; Rahimov F; Kawahara G; Widrick JJ; Kunkel LM
J Clin Invest; 2014 Jun; 124(6):2651-67. PubMed ID: 24789910
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
